Introduction
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal conditions with a symptombased diagnosis. IBS is characterized by abdominal pain and discomfort, bloating, and alteration of bowel habits in the absence of any organic cause. The pathogenesis of IBS remains uncertain, but recent studies have considered the role of inflammation, alterations in fecal flora, bacterial overgrowth, and a chronic low-grade inflammation of the gastrointestinal mucosa (1) . Diagnosis is symptom-based because there are no biological, anatomical, physiological, or colonoscopic markers for IBS and diagnostic criteria should be fulfilled by the patients. Well-known algorithms for diagnosis include the Manning criteria, the obsolete Rome I and II criteria, the Kruis criteria, and the more recent Rome III process (2) . Furthermore, a variety of dietary, pharmacological, and psychological treatments have been studied in patients with IBS, but there is no proven effective management for IBS. It also has significant effects on quality of life with a high social cost. The total cost of IBS in the United States has been estimated at $21.7-$30 billion (3) .
Several conditions with diarrhea may present as diarrhea-predominant IBS, including parasitic infections like giardiasis, fructose and bile acid malabsorption, small intestinal bacterial overgrowth, inflammatory bowel diseases, celiac disease, and microscopic colitis (MC). MC may have a role among these conditions owing to its similar symptoms and endoscopic appearance. Evaluation of such patients may lead to a misdiagnosis of MC in patients with IBS. Chronic diarrhea is the main symptom both in patients with MC and diarrhea-predominant IBS, but collagenous colitis and/or lymphocytic colitis might be related to constipation and they are often accompanied by abdominal pain (4, 5) . Furthermore, the mucosa appears grossly normal or nearly normal at colonoscopy (6) . In the presence of appropriate clinical symptoms, the diagnosis of MC is established histologically, based on the presence of intraepithelial lymphocytosis and a mixed inflammatory infiltrate in the lamina propria (7) . Many cases of MC are self-limiting and silent, whereas others are symptomatic for years in a relapsing or continuous pattern. Symptoms of MC are often attributed to IBS, so histologic investigations should be performed for the above-mentioned IBS patients.
This trial was designed to investigate the presence and incidence of MC and to reveal associated factors related to MC, prospectively in patients diagnosed with IBS by Rome III criteria.
Materials and methods

Selection of patients and the control group
After giving informed consent, 91 consecutive patients were included in group I. These were patients presenting to the Gastroenterology Department complaining of abdominal pain, dyspepsia, distension, and changes in defecation habit who were diagnosed with IBS by Rome III Criteria and for whom a colonoscopic examination was requested. None of the patients had a systemic illness or were using any medications.
The control group for microscopic colitis (group II) consisted of 41 patients considered as eligible for colonoscopic investigation due to specific complaints despite meeting Rome III criteria. In these patients, colonoscopic examination was recommended for screening purposes due to a familial history of colon cancer. Informed consent was obtained from all patients before beginning the colonoscopic examination.
Endoscopic examination
For all study subjects, a total colonoscopic examination was performed using a Pentax EC 3840 endoscope following appropriate colon cleansing, and 2 biopsies were obtained from each of the cecum, ascending, transverse, descending, and rectosigmoid colon segments for histopathological investigation.
Pathological examination
Tissue samples obtained during colonoscopic investigation were delivered to the pathology department in solutions containing formaldehyde. After the preparation of 5-µm-thick paraffin blocks, the colon biopsies were dyed with hematoxylin-eosin (H-E) and Gömöri trichrome stains. All biopsy specimens were reviewed by an expert gastrointestinal pathologist who was not aware of the patients' groups.
Criteria for microscopic colitis
Collagenous colitis (CC) and lymphocytic colitis (LC) are 2 subtypes of MC. LC is defined by the flattening of the surface epithelium, degenerative cuboidal changes, significant intraepithelial lymphocyte infiltration (more than 20 lymphocytes for every 100 epithelial cells), and mononuclear cell infiltration in the lamina propria. CC was defined by subepithelial collagenous bands >10 µm in thickness that were dyed with trichrome and H-E stains (8).
Statistical analysis
Data from this trial were assessed using SPSS 17.0. A Student's t test and analysis of variance were used for two-group and three-group comparisons respectively. A chi-square test was used for dependence tests of the categorical data. The level of significance was 0.05, with P < 0.05 considered significant and P > 0.05 considered not significant.
Ethical considerations
This study was approved by the Gazi University Local Medical-Surgical Research and Drug Ethical Committee.
Results
The age and sex distribution of the patients are similar between the two groups (P > 0.05, The patients with IBS were subdivided according to Rome III criteria into three groups: 22 (24.17%) were constipation-predominant, 55 (60.43%) were diarrheapredominant, and 14 (15.38%) were mixed diarrhea and constipation. Symptom duration was found to be significantly shorter in the diarrhea-predominant IBS patients compared to the constipation-predominant and mixed type patients (P = 0.0001, P = 0.005, and P < 0.05, respectively)
In the diarrhea-predominant IBS group, nine patients (9.89%) were histopathologically found to have MC; seven were found to have LC (7.69%), and two had CC (2.19%). None of the patients in group II were diagnosed with MC (P = 0.007). No MC was diagnosed in the constipationpredominant and mixed type IBS group. The distribution of the seven cases with LC revealed two in the rectosigmoid, two in the descending colon and rectosigmoid, one in the cecum and ascending colon, one in the ascending, transverse, descending and rectosigmoid colon, and one with whole colon involvement. The rectum was spared in one case.
In the two patients with CC, descending colon involvement was observed in one case, and rectosigmoid colon involvement was observed in the other.
An evaluation of the nine patients with MC based on demographic and clinical characteristics revealed that six of the LC patients were female and one was male, with a mean age of 44.6 ± 1.7; furthermore, one of the CC cases was male while one was female, with a mean age of 57 ± 3.0. Their mean symptom duration was 44.6 ± 1.7 months. All of these patients had been diagnosed with diarrheapredominant IBS. Their mean symptom duration was 36.6 ± 4.1 months ( Table 2 ).
Discussion
In this study we found that some patients presenting with IBS symptoms can be diagnosed with MC. MC shows a clinical similarity to IBS. LC and/or CC may be related to constipation, although chronic diarrhea is the main symptom in patients with both MC and diarrheapredominant IBS. In the literature, some studies reported that many patients suffered not from episodes of watery diarrhea but chronic constipation (5) . In a trial assessing symptomatic similarities between IBS and MC, diarrheapredominant IBS was reported in 28% of the MC cases as per the Rome II criteria (8) . The present trial shows that all patients with MC were included in the diarrheapredominant IBS patient group (Figure) .
In a previous study, it was reported that alternative diagnoses should be investigated for IBS patients who lack response to treatment and are followed up over an extended period (9) . In our study, in all cases where MC was detected, the symptoms were found to last for a minimum of 6 months to a maximum of 144 months. This indicates that some of our patients were under monitoring with a misdiagnosis of IBS for over 10 years. In female diarrhea-predominant IBS patients with symptoms persisting over an extended period, the potential presence of MC should be kept in mind. There have been a few trials in the literature that investigated the coexistence of MC and IBS. In a recent trial, colon biopsy samples and clinical data of 131 patients diagnosed with MC (84 LC and 47 CC) and 110 patients without an MC diagnosis from whom a biopsy was obtained due to chronic diarrhea were evaluated retrospectively (10) . In that study, the presence of symptoms required for IBS diagnosis by Rome II was demonstrated in 56% of the histologically diagnosed MC cases. Retrospectively, 43 of these patients (33%) were found to have been monitored with a diagnosis of IBS prior to biopsy. In the patient group consisting of 110 diarrhea patients without MC, a rate of 34% was detected for IBS diagnostic criteria. Intergroup comparison showed a statistically significant higher IBS diagnosis in the MC group compared to the others.
A prospective trial by Chadwick et al. evaluated colonoscopic biopsies of 77 patients diagnosed with IBS as per the Rome I criteria and established a histologic diagnosis of MC in 10% (11) . In another trial, seven of 30 patients (23.3%) were diagnosed with IBS according to the Manning criteria and one patient out of 20 in the control group (5%) was found to have LC; the difference was statistically significant. None of the patients were found to have CC (12) . A Turkish study reported the prevalence of microscopic colitis in 30 patients diagnosed with IBS by the Manning criteria to be 23% compared with 5% in a control group of 20 patients to be screened for colon cancer or nonulcer dyspepsia (12) . In our study, investigation of biopsy samples obtained by total colonoscopy from patients diagnosed with IBS using the Rome III criteria revealed MC in nine patients (9.89%) with seven found to have LC (7.69%) and two CC (2.19%). None of the patients in the control group had MC. In our study, all of the patients with MC were in the diarrhea-predominant IBS group.
To rule out MC in patients diagnosed with diarrheapredominant IBS, a histopathological assessment of colonoscopic biopsies is required. Some trials recommend only rectal biopsy (13, 14) while some report that rectal biopsy alone is insufficient due to the variable anatomic distribution of MC cases (15, 16) and the higher level of proximal colon involvement compared to distal involvement (17) . In our series, assessment of the seven cases with LC by colon segment revealed cecum involvement in one case, a combination of cecum, transverse colon, descending colon, and rectosigmoid colon involvement in two cases, a combination of descending colon and rectosigmoid colon involvement in two cases, and rectosigmoid colon involvement in two cases. In the two patients with CC, descending colon and rectosigmoid colon involvement was observed in one, and rectosigmoid colon involvement was observed in the other. Based on the literature data and the results from our trial, we think that right colon biopsies are necessary for diagnosis in diarrhea-predominant IBS patients with a negative rectal biopsy in the event of suspicion of MC.
In conclusion, among patients diagnosed with IBS, those with symptoms persisting for a long period, those with diarrhea-predominant IBS and a short duration of symptoms, or those with a poor response to treatment, the actual diagnosis may be MC with symptoms overlapping with IBS. As is also indicated in the literature and by our trial, we conclude that histological investigations should be performed in the above-mentioned IBS patients by obtaining biopsies from the whole colon, as biopsies obtained only from the rectosigmoid are not adequate for the diagnosis of MC. This is important to avoid unnecessary, excessive, and long-term drug use by patients as well as to prevent losses in workforce efficiency and to reduce morbidity. Figure.
The number of IBS patients and distribution of MC patients in the diarrhea-predominant IBS group.
